Improving glycemic control in critically ill patients: personalized care to mimic the endocrine pancreas

[1]  J. Vanhelst,et al.  Protocol of a randomised controlled trial assessing the impact of physical activity on bone health in children with inflammatory bowel disease , 2020, BMJ Open.

[2]  J. Geoffrey Chase,et al.  Generalisability of a Virtual Trials Method for Glycaemic Control in Intensive Care , 2018, IEEE Transactions on Biomedical Engineering.

[3]  B. De Moor,et al.  Software-guided versus nurse-directed blood glucose control in critically ill patients: the LOGIC-2 multicenter randomized controlled clinical trial , 2017, Critical Care.

[4]  P. Kalfon,et al.  Continuous glucose monitoring in the ICU: clinical considerations and consensus , 2017, Critical Care.

[5]  J. Geoffrey Chase,et al.  Untangling glycaemia and mortality in critical care , 2017, Critical Care.

[6]  F. Bloomfield,et al.  Computer-determined dosage of insulin in the management of neonatal hyperglycaemia (HINT2): protocol of a randomised controlled trial , 2017, BMJ Open.

[7]  R. Tanenberg,et al.  USE OF A COMPUTER-GUIDED GLUCOSE MANAGEMENT SYSTEM TO IMPROVE GLYCEMIC CONTROL AND ADDRESS NATIONAL QUALITY MEASURES: A 7-YEAR, RETROSPECTIVE OBSERVATIONAL STUDY AT A TERTIARY CARE TEACHING HOSPITAL. , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[8]  Henrik Madsen,et al.  Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes , 2017, Journal of diabetes science and technology.

[9]  Claudio Cobelli,et al.  Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator , 2016, Diabetes technology & therapeutics.

[10]  CobelliClaudio,et al.  Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator. , 2016 .

[11]  R. Hovorka,et al.  Glucose Control in the ICU , 2016, Journal of diabetes science and technology.

[12]  L. Magni,et al.  Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home , 2016, Diabetes Care.

[13]  Balázs Benyó,et al.  Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis , 2016, Annals of Intensive Care.

[14]  Claudio Cobelli,et al.  One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator , 2016, IEEE Transactions on Biomedical Engineering.

[15]  U. Jaschinski,et al.  Space GlucoseControl system for blood glucose control in intensive care patients - a European multicentre observational study , 2015, BMC Anesthesiology.

[16]  J. Chase,et al.  Glucose control positively influences patient outcome: A retrospective study. , 2015, Journal of critical care.

[17]  J. Preiser,et al.  Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults , 2015, Critical Care.

[18]  K. Hanazaki,et al.  Intensive Versus Intermediate Glucose Control in Surgical Intensive Care Unit Patients , 2014, Diabetes Care.

[19]  M. Sorine,et al.  Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial , 2014, Intensive Care Medicine.

[20]  S. Inzucchi,et al.  Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin. , 2013, Diabetes technology & therapeutics.

[21]  T. Rice.  Gluttony in the intensive care unit: time to push back from the consensus table. , 2013, American journal of respiratory and critical care medicine.

[22]  J. Geoffrey Chase,et al.  Impact of variation in patient response on model-based control of glycaemia in critically ill patients , 2013, Comput. Methods Programs Biomed..

[23]  B. De Moor,et al.  LOGIC-Insulin Algorithm–Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness , 2013, Diabetes Care.

[24]  T. Okabayashi,et al.  Technical Challenges and Clinical Outcomes of Using a Closed-Loop Glycemic Control System in the Hospital , 2013, Journal of diabetes science and technology.

[25]  A. Koeppen,et al.  Central role and mechanisms of β‐cell dysfunction and death in friedreich ataxia–associated diabetes , 2012, Annals of neurology.

[26]  J. Chase,et al.  Glycemic Levels in Critically Ill Patients: Are Normoglycemia and Low Variability Associated with Improved Outcomes? , 2012, Journal of diabetes science and technology.

[27]  J. Geoffrey Chase,et al.  STAR Development and Protocol Comparison , 2012, IEEE Transactions on Biomedical Engineering.

[28]  Tanya M. Teslovich,et al.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.

[29]  M. Siegel,et al.  Adapting to the new consensus guidelines for managing hyperglycemia during critical illness: the updated Yale insulin infusion protocol. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[30]  G. Steil,et al.  The Identifiable Virtual Patient Model: Comparison of Simulation and Clinical Closed-Loop Study Results , 2012, Journal of diabetes science and technology.

[31]  Thomas Desaive,et al.  Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control , 2011, Annals of intensive care.

[32]  R. Hovorka,et al.  Evaluating glycemic control algorithms by computer simulations. , 2011, Diabetes technology & therapeutics.

[33]  Thomas Desaive,et al.  Physiological modeling, tight glycemic control, and the ICU clinician: what are models and how can they affect practice? , 2011, Annals of intensive care.

[34]  Christopher E. Hann,et al.  Tight glycemic control in critical care - The leading role of insulin sensitivity and patient variability: A review and model-based analysis , 2011, Comput. Methods Programs Biomed..

[35]  Christopher E. Hann,et al.  A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients , 2011, Comput. Methods Programs Biomed..

[36]  Thomas Desaive,et al.  Validation of a model-based virtual trials method for tight glycemic control in intensive care , 2010, Biomedical engineering online.

[37]  Thomas Desaive,et al.  Organ failure and tight glycemic control in the SPRINT study , 2010, Critical care.

[38]  Roman Hovorka,et al.  Hospital glucose control: safe and reliable glycemic control using enhanced model predictive control algorithm in medical intensive care unit patients. , 2010, Diabetes technology & therapeutics.

[39]  Steen Andreassen,et al.  A simulation model of insulin saturation and glucose balance for glycemic control in ICU patients , 2010, Comput. Methods Programs Biomed..

[40]  B. S. Nielsen,et al.  The Glucosafe system for tight glycemic control in critical care: a pilot evaluation study. , 2010, Journal of critical care.

[41]  Johan Groeneveld,et al.  A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study , 2009, Intensive Care Medicine.

[42]  Richard Hellman,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[43]  J. Preiser,et al.  Stress hyperglycaemia , 2009, The Lancet.

[44]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[45]  R. Hovorka,et al.  Comparison of Three Protocols for Tight Glycemic Control in Cardiac Surgery Patients , 2009, Diabetes Care.

[46]  Claudio Cobelli,et al.  Effects of Type 2 Diabetes on Insulin Secretion, Insulin Action, Glucose Effectiveness, and Postprandial Glucose Metabolism , 2009, Diabetes Care.

[47]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[48]  Ameen Abu-Hanna,et al.  A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset , 2008, Critical care.

[49]  R. Hovorka,et al.  A simulation model of glucose regulation in the critically ill , 2008, Physiological measurement.

[50]  R. Juneja,et al.  Safety and Effectiveness of a Computerized Subcutaneous Insulin Program to Treat Inpatient Hyperglycemia , 2008, Journal of diabetes science and technology.

[51]  Roman Hovorka,et al.  In Silico Testing—Impact on the Progress of the Closed Loop Insulin Infusion for Critically Ill Patients Project , 2008, Journal of diabetes science and technology.

[52]  J. Geoffrey Chase,et al.  Impact of Human Factors on Clinical Protocol Performance: A Proposed Assessment Framework and Case Examples , 2008, Journal of diabetes science and technology.

[53]  Dominic S. Lee,et al.  Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change , 2008, Critical care.

[54]  Malgorzata E. Wilinska,et al.  Tight glycaemic control by an automated algorithm with time-variant sampling in medical ICU patients , 2008, Intensive Care Medicine.

[55]  Christopher E. Hann,et al.  Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care , 2008, Comput. Methods Programs Biomed..

[56]  Rolf Rossaint,et al.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.

[57]  Roman Hovorka,et al.  Blood glucose control by a model predictive control algorithm with variable sampling rate versus a routine glucose management protocol in cardiac surgery patients: a randomized controlled trial. , 2007, The Journal of clinical endocrinology and metabolism.

[58]  Niels Haverbeke,et al.  Glycemia Prediction in Critically Ill Patients Using an Adaptive Modeling Approach , 2007, Journal of diabetes science and technology.

[59]  Daleen Aragon,et al.  Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. , 2006, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[60]  Thomas Lotz,et al.  A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. , 2006, Diabetes technology & therapeutics.

[61]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[62]  Jaap E Tulleken,et al.  Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature , 2006, Critical care.

[63]  Mathijs Vogelzang,et al.  Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit , 2005, BMC Medical Informatics Decis. Mak..

[64]  Bruce W Bode,et al.  Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. , 2005, Diabetes care.

[65]  B. Ahrén,et al.  Type 2 diabetes, insulin secretion and beta-cell mass. , 2005, Current molecular medicine.

[66]  James Stephen Krinsley,et al.  Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. , 2004, Mayo Clinic proceedings.

[67]  P. Marik,et al.  Stress-hyperglycemia, insulin and immunomodulation in sepsis , 2004, Intensive Care Medicine.

[68]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[69]  Steen Andreassen,et al.  A model of the endogenous glucose balance incorporating the characteristics of glucose transporters , 2000, Comput. Methods Programs Biomed..

[70]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[71]  R. DeFronzo,et al.  Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. , 1989, The American journal of physiology.

[72]  H. Chandalia,et al.  STRESS HYPERGLYCAEMIA , 1984, The Lancet.

[73]  Jennifer L. Dickson,et al.  Model-based glycaemic control: methodology and initial results from neonatal intensive care , 2017, Biomedizinische Technik. Biomedical engineering.

[74]  Masafumi Matsuda,et al.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. , 2005, The Journal of clinical endocrinology and metabolism.

[75]  S. Gabriel,et al.  Systematic Review of the Literature , 2021, Adherence to Antiretroviral Therapy among Perinatal Women in Guyana.

[76]  Claudio Cobelli,et al.  Modelling metholodology for physiology and medicine , 2001 .

[77]  R N Bergman,et al.  Assessment of insulin sensitivity in vivo. , 1985, Endocrine reviews.